FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹550 Cr | ₹615 Cr | ₹730 Cr | ₹690 Cr | ₹622 Cr |
What is the latest Total Current Liabilities ratio of FDC ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹550 Cr |
| Mar2024 | ₹615 Cr |
| Mar2023 | ₹730 Cr |
| Mar2022 | ₹690 Cr |
| Mar2021 | ₹622 Cr |
How is Total Current Liabilities of FDC Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹550 Cr | -10.54 | |
| Mar2024 | ₹615 Cr | -15.68 | |
| Mar2023 | ₹730 Cr | 5.67 | |
| Mar2022 | ₹690 Cr | 11.03 | |
| Mar2021 | ₹622 Cr | - | |
Compare Total Current Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,868.5 Cr | -2.3% | 9.7% | -15.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -2.3% |
9.7% |
-15.8% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses